Nezam Afdhal

Nezam Afdhal

Harvard University - Cambridge / United States
Others
AD Scientific Index ID: 1388918
person_outline Nezam Afdhal's MOST POPULAR ARTICLES
1-) Liver cirrhosisD Schuppan, NH AfdhalThe Lancet 371 (9615), 838-851, 200825782008
2-) Ledipasvir and sofosbuvir for untreated HCV genotype 1 infectionN Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...New England Journal of Medicine 370 (20), 1889-1898, 201420452014
3-) Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyP Marcellin, E Gane, M Buti, N Afdhal, W Sievert, IM Jacobson, ...The Lancet 381 (9865), 468-475, 201317802013
4-) Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infectionN Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ...New England Journal of Medicine 370 (16), 1483-1493, 201417302014
5-) Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infectionGR Foster, N Afdhal, SK Roberts, N Bräu, EJ Gane, S Pianko, E Lawitz, ...New England Journal of Medicine 373 (27), 2608-2617, 201510802015